Prenatal Diagnosis

Cover image for Vol. 35 Issue 8

Editor-in-Chief: Professor Diana W. Bianchi, Boston, USA

Impact Factor: 3.268

ISI Journal Citation Reports © Ranking: 2014: 11/79 (Obstetrics & Gynecology); 57/167 (Genetics & Heredity)

Online ISSN: 1097-0223

Editors' Choice


2015 (Volume 35)


July (Issue 7)

Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?
K. D. Lichtenbelt et al.

June (Issue 6)

Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms
N. B. Burger et al.

May (Issue 5)

The use of imaging technology in the assessment of the fetal inflammatory response syndrome—imaging of the fetal thymus
Y. Sciaky-Tamir et al.

April (Issue 4)

Long-term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening
O. Äyräs et al.

March (Issue 3)

The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature
F. Prefumo et al.

February (Issue 2)

Maternal body mass index influences umbilical artery Doppler velocimetry in physiologic pregnancies
L. Sarno et al.

January (Issue 1)

Perinatal outcome after maternal primary cytomegalovirus infection in the first trimester: a practical update and counseling aid
L. Hui & G. Wood


2014 (Volume 34)


December (Issue 13)

Early detection of fetal cardiac abnormalities: how effective is it and how should we manage these patients?
S-A. B. Clur & C. M. Bilardo

December (Issue 12)

Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center
A. Krishnan et al.

November (Issue 11)

Screening for Down syndrome – incidental diagnosis of other aneuploidies
C. Davis et al.

October (Issue 10)

Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
S. Chandrasekharan et al.

September (Issue 9)

NIPT: current utilization and implications for the future of prenatal genetic counselling
A. Buchanan et al.

August (Issue 8)

Early fetal echocardiography: congenital heart disease detection and diagnostic accuracy in the hands of an experienced fetal cardiology program
J. I. Pike et al.

June (Issue 6)

Role of the second-trimester ‘genetic sonogram’ for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing
A. O. Odibo & A. Ghidini

May (Issue 5)

Fetal diagnostic indications for second and third trimester outpatient pregnancy termination
W. M. Hern

April (Issue 4)

Maternal obesity and risk of Down syndrome in the offspring
E. Hildebrand et al.

March (Issue 3)

Prenatal diagnosis of nonsyndromic congenital heart defects
E. C. Ailes et al.

February (Issue 2)

Complexity of noninvasive prenatal screening and diagnostic testing for an unbalanced translocation involving chromosomes 5 and 18
H. Feenstra et al.

January (Issue 1)

In case you missed it: the Prenatal Diagnosis section editors bring you the most significant advances of 2013
D. W. Bianchi et al.


2013 (Volume 33)


October (Issue 10)

Evolution of gender options in multiple pregnancy management
M. I. Evans et al.

September (Issue 9)

Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review
I. T. M. Lindenburg et al.

August (Issue 8)

A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome
O. Picone et al.

July (Issue 7)

Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma
E. Wang et al.

May (Issue 5)

Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA
L. S. Chitty et al.

April (Issue 4)

Early pregnancy vaginal fluid phosphorylated insulin-like growth factor binding protein-1 predicts preterm delivery
H. Kallioniemi et al.

March (Issue 3)

The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine
N. C. Rose et al.

January (Issue 1)

Current controversies in prenatal diagnosis 1: screening for fragile X syndrome
Y. Yaron et al.


2012 (Volume 32)


December (Issue 13)

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors
S. Dan et al.

December (Issue 12)

Prenatal genetic counseling and consanguinity
A. Posch et al.

November (Issue 11)

Fetal forearm anomalies: prenatal diagnosis, associations and management strategy
E. Pajkrt et al.

October (Issue 10)

Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound
L. G. Shaffer et al.

September (Issue 9)

Outcomes of foetuses with small head circumference on second-trimester ultrasonography
B. Deloison et al.

August (Issue 8)

DNA Sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations
J. A. Canick et al.

July (Issue 7)

Effects of chemotherapy during pregnancy on the maternal and fetal heart
M. M. Gziri et al.

June (Issue 6)

Fetal varicella – diagnosis, management, and outcome
L. Mandelbrot

May (Issue 5)

Male genital abnormalities in intrauterine growth restriction
S. F. Nemec et al.

April (Issue 4)

Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial
R. J. Wapner et al.

March (Issue 3)

MR imaging of the fetal musculoskeletal system
S. F. Nemec et al.

February (Issue 2)

Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011)
J. L. Natoli et al.

January (Issue 1)

Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
A. B. Sparks et al.


2011 (Volume 31)


December (Issue 13)

Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases
F. Fiorentino et al.

December (Issue 12)

Fetal intracranial translucency and cisterna magna at 11 to 14 weeks: reference ranges and correlation with chromosomal abnormalities
I. Papastefanou et al.

November (Issue 11)

The correlation between lung volume and liver herniation measurements by fetal MRI in isolated congenital diaphragmatic hernia: a systematic review and meta-analysis of observational studies
S. Mayer et al.

October (Issue 10)

Fragile X analysis of 1112 prenatal samples from 1991 to 2010
S. L. Nolin et al.

September (Issue 9)

Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype
M. Bakker et al.

August (Issue 8)

Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women
A. T. Bombard et al.

July (Issue 7)

Fetal therapy: practical ethical considerations
Y. Ville

June (Issue 6)

Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011
P. Benn et al.

May (Issue 5)

Parvovirus B19 infection in pregnancy: new insights and management
E. P. de Jong et al.

April (Issue 4)

Demographic differences in Down syndrome livebirths in the US from 1989 to 2006
J. F. X. Egan et al.

March (Issue 3)

Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?
T-H. Bui et al.

February (Issue 2)

Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome
Y. M. de Mooij et al.

January (Issue 1)

Screening for fetal aneuploidies at 11 to 13 weeks
K. H. Nicolaides


2010 (Volume 30)


December (Issue 12-13)

Targeted array comparative genomic hybridisation (array CGH) identifies genomic imbalances associated with isolated congenital diaphragmatic hernia (CDH)
K. Srisupundit et al.

November (Issue 11)

Assessment of regional right ventricular longitudinal functions in fetus using velocity vector imaging technology
D-r. Pu et al.

October (Issue 10)

Ancillary benefits of prenatal maternal serum screening achieved in the California program
N. Neely Kazerouni et al.

September (Issue 9)

Down syndrome risk calculation for a twin fetus taking account of the nuchal translucency in the co-twin
H. Cuckle & R. Maymon

August (Issue 8)

Minimally invasive fetal postmortem examination using magnetic resonance imaging and computerised tomography: current evidence and practical issues
S. Thayyil et al.

July (Issue 7)

The making of fetal surgery
J. A. Deprest et al.

June (Issue 6)

QF-PCR as a stand-alone test for prenatal samples: the first 2 years' experience in the London region
A. Hiills et al.

May (Issue 5)

Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies
M. P. H. Koster et al.

April (Issue 4)

First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction
Y. Zhong et al.

March (Issue 3)

Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11–13 weeks
L. C. Y. Poon et al.

February (Issue 2)

Increased nuchal translucency in euploid fetuses—what should we be telling the parents?
C. M. Bilardo et al.

January (Issue 1)

Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction
W. P. Robinson et al.

SEARCH

SEARCH BY CITATION